Compare Global X CleanTech (CTEC) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X CleanTech vs Stryker Corporation — how do they compare? Global X CleanTech trades at $56.36 (market cap $24.57M), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 4324× Global X CleanTech's market cap, and Stryker Corporation pays a 1.27% dividend while Global X CleanTech pays none. Which is the better fit depends on your goals — on Pluang, investors hold Global X CleanTech for 42 Days and Stryker Corporation for 21 Days on average.
| CTEC | SYK | |
|---|---|---|
Market Cap | $24.57M | $106.24B |
Volume | 1,220 | 2,982,001 |
Sector | Sector/Thematic | Health |
52-Week High | $78.11 | $388.35 |
52-Week Low | $50.82 | $269.75 |
Typical Hold Time | 42 Days | 21 Days |
Enterprise Value | — | $117.70B |
Dividend Yield | — | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CTEC trades at $56.36, up 0.25% today, with a bullish technical signal from moving averages and strong trend strength (ADX 46.60). The stock faces resistance near $58 and support at $57. Key financial ratios like P/E and P/S are not provided, limiting fundamental clarity.
The outlook hinges on upcoming earnings to validate growth. Risks include opaque financials and market volatility. Analyst sentiment is mixed, with institutional interest needed to confirm the bullish technical setup.
Stryker (SYK) trades at $277.33, up 0.7% on the day, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279, while fundamentals remain solid with a 14.43% net income margin and strong analyst consensus. Recent news highlights ongoing legal scrutiny related to a manufacturing issue disclosed in September 2026, which caused an 8.8% stock drop, but the company continues to innovate with product launches like Prophecy surgical planning.
The outlook for SYK is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities include robust profitability and growth in medical technology, but risks persist from legal investigations and potential operational disruptions. Investors should weigh strong analyst support against near-term sentiment headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Global X CleanTech
CTEC invests in companies at the forefront of the clean technology industry. It focuses on disruptive innovations in renewable energy production, energy storage, smart grids, and energy efficiency, with top holdings like Enphase and First Solar.
Read more on CTEC →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
